ID
14004
Description
Idarubicin Overcomes MDR1 Induced Chemoresistance With Higher Induction Remission Rate and Quality Than Daunorubicin in Acute Myeloid Leukemia Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01889407
Link
https://clinicaltrials.gov/show/NCT01889407
Keywords
Versions (1)
- 3/21/16 3/21/16 -
Uploaded on
March 21, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Acute Myeloid Leukemia NCT01889407
Eligibility Acute Myeloid Leukemia NCT01889407
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Acute Promyelocytic Leukemia
Data type
boolean
Alias
- UMLS CUI [1]
- C0023487
Description
Systemic infection
Data type
boolean
Alias
- UMLS CUI [1]
- C0243026
Description
Medical condition
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0525058
- UMLS CUI [1,2]
- C0009488
Description
Positive urine pregnancy test
Data type
boolean
Alias
- UMLS CUI [1]
- C0430059
Similar models
Eligibility Acute Myeloid Leukemia NCT01889407
- StudyEvent: Eligibility
C0009488 (UMLS CUI [1,2])